Comparison of pre-expiry and generic price for drugs U.S. 2015

Comparison of brand pre-expiry price and generic price of selected drugs in the United States as of 2015 (in U.S. dollars)

by Statista Research Department, last edited Nov 14, 2016
Comparison of pre-expiry and generic price for drugs U.S. 2015 This statistic shows the comparison of brand pre-expiry price and generic price of select drugs in the United States in 2015. The price for Zofran was 21.67 U.S. dollars before patent expiration in 2006, whereas the generic price for the same drug was 0.24 U.S. dollars in 2015.
Show more

Comparison of brand pre-expiry price and generic price of selected drugs in the United States as of 2015 (in U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Generics and biosimilars
Generics and biosimilars

All Information
in one Presentation

Generics and biosimilars

Everything On "Generics and biosimilars" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Generics and biosimilars"
  • Global overview
  • Top companies
  • U.S. market
  • Patent expiration
  • Savings
  • Biosimilars
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.